Upper Respiratory Infections: Clinical Trials

14 trials for Upper Respiratory Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 1 unknown, 1 withdrawn. 6 Not applicable, 3 Phase 4, 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable6Completed 4, Unknown 1, Withdrawn 1
Phase 43Completed 3
Phase 32Completed 2
Phase 21Completed 1

Follow Upper Respiratory Infections: new trials by email Literature Review of Upper Respiratory Infections trials Research Report on Upper Respiratory Infections

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Two Nasal Products Based on Diluted Seawater in the Treatment of Upper Respiratory Infections/Conditions
administration of an isotonic seawater solution (9g/L) in the nose, administration of a hypertonic seawater solution (21g/L) in the nose - Rhinitis, Sinusitis
Not applicableCompletedYSLab892025-03-182026-08-19
Use of a Behavioral Economic Intervention to Reduce Antibiotic Prescription for Upper Respiratory Infections
Nudge using Behavioral Economic Interventions, Standard Practices to Reduce Health System Antibiotic Prescription - Antibiotics, Upper Respiratory Infections
Not applicableCompletedUniversity of California, Los Angeles25002015-05-292018-05-02
Evaluation of Accuracy and Ease of Use of the FilmArray™ Respiratory Panel (RP EZ) in a CLIA-Waived Clinical Setting
Upper Respiratory Infections
CompletedBioFire Diagnostics, LLC10822014-11-012015-07-24
DBRCT on the Effect of Wheat Polysaccharides on Common Cold Infections in Elderly
wheat polysaccharides, maltodextrin - Upper Respiratory Infections, Common Cold
Phase 2CompletedClinical Research Center Kiel GmbH2472014-09-012016-04-12
Nutritional Intervention and Respiratory Infections in Older Subjects
Multivitamins and minerals - Upper Respiratory Infections, Lower Respiratory Tract Infections
Not applicableUnknownCorporacion Ecuatoriana de Biotecnologia3202013-10-012013-10-29
Children Immune Functions(2)
Milk with Bifidobacteria, Milk with non replicating lactobacilli, placebo - Diarrhea, Upper Respiratory Infections
Not applicableCompletedSociété des Produits Nestlé (SPN)6042012-11-012013-12-12
Children Immune Functions
heat-treated lactobacilli or placebo - Diarrhea, Upper Respiratory Infections
Not applicableCompletedSociété des Produits Nestlé (SPN)3742012-10-012013-08-27
Warming Sensation Intensity and Acceptability of the Flavour, Local Tolerability of Paracetamol 500 mg + Pseudoephedrine 30 mg Syrup in Patients Suffering a URTI
IFF flavor 316 282, Paracetamol, Pseudoephedrine - Upper Respiratory Infections
Phase 3CompletedNovartis562012-05-012013-08-07
Warming Sensation Intensity and Acceptability of the Flavour, Local Tolerability of Paracetamol 500 mg + Phenylephrine 10mg + Guaifenesin 200 mg Syrup in Patients Suffering a Upper Respiratory Tract Infection (URTI)
IFF flavor 316 282, Paracetamol , Phenylephrine, Guaifenesin - Upper Respiratory Infections
Phase 3CompletedNovartis512012-03-012013-11-11
Effectiveness of a Handwashing Programme in the Prevention of School Absenteeism Due to Respiratory Infections
hand sanitizer - Upper Respiratory Infections, Influenza
Phase 4CompletedFundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental16402009-10-012012-11-19
Effects of Echinacea in Children
Echinacea purpurea 100 mg/ml in liquid formulation, placebo - Upper Respiratory Infections
Not applicableWithdrawnUniversity of Washington2008-11-012015-12-02
Remifentanil and Laryngeal Reflex Responses in Pediatric Patients With URI
propofol, remifentanil - Upper Respiratory Infections
Phase 4CompletedThomas Erb622008-01-012015-10-30
A Study to Evaluate the Efficacy of the Nasal Antiseptic, PrevinC, When Administered for the RiskReduction of Rhinitis in Subjects Who Work for Child Day Care Centers
PrevinC, placebo - Upper Respiratory Infections
Phase 4CompletedBioHealth Technologies Inc.2005-02-012019-01-16
Inter-Mountain Project on Antimicrobial Resistance and Therapy (IMPART)
Antimicrobial Prescribing Decision Support - Upper Respiratory Infections
CompletedUniversity of Utah130002001-10-012006-05-05

Narrower conditions

Respiratory Tract Infections (14)  ·  Common Cold (2)  ·  Diarrhea (2)  ·  Communicable Diseases (1)  ·  Influenza, Human (1)  ·  Laryngeal Diseases (1)  ·  Pathologic Complete Response (1)  ·  Rhinitis (1)  ·  Sinusitis (1)

Broader conditions

Infections (14)  ·  Respiratory Tract Diseases (14)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Otorhinolaryngologic Diseases (2)  ·  Picornaviridae Infections (2)  ·  RNA Virus Infections (2)  ·  Signs and Symptoms (2)  ·  Signs and Symptoms, Digestive (2)  ·  Virus Diseases (2)  ·  Disease Attributes (1)  ·  Disease Progression (1)  ·  Nose Diseases (1)  ·  Orthomyxoviridae Infections (1)  ·  Paranasal Sinus Diseases (1)  ·  Pathologic Processes (1)

Interventions

Acetaminophen (2)  ·  Echinacea extract (1)  ·  Geritol (1)  ·  Guaifenesin (1)  ·  Hand Sanitizers (1)  ·  Milk (1)  ·  Minerals (1)  ·  Phenylephrine (1)  ·  Propofol (1)  ·  Pseudoephedrine (1)  ·  Remifentanil (1)  ·  maltodextrin (1)

Sponsors

Novartis (2)  ·  Société des Produits Nestlé (SPN) (2)  ·  BioFire Diagnostics, LLC (1)  ·  BioHealth Technologies Inc. (1)  ·  Clinical Research Center Kiel GmbH (1)  ·  Corporacion Ecuatoriana de Biotecnologia (1)  ·  Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental (1)  ·  Thomas Erb (1)  ·  University of California, Los Angeles (1)  ·  University of Utah (1)  ·  University of Washington (1)  ·  YSLab (1)

Countries

United States (3)  ·  Canada (2)  ·  Ecuador (1)  ·  Germany (1)  ·  Indonesia (1)  ·  Mexico (1)  ·  Poland (1)  ·  Switzerland (1)

Top investigators

Carlos A. Mena Cedillos, MD (1)  ·  Christiane Laue, MD (1)  ·  Ernestina Azor, MD, PhD (1)  ·  James A Taylor (1)  ·  Matthew H. Samore, MD (1)  ·  Saptawati Bardosono, MSc (1)  ·  Thomas O Erb, MD (1)

Results publications

PMID 16278358

NIH funding

U01AT002400 (1)